⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Neo Launches with $100M to Secure AI Software Across the Enterprise
globenewswire.com
S
PANW
SHOP
NVDA
MSFT
GOOG
AMZN
CRM
ADBE
IBM
INTC
AMD
QCOM
META
TWLO
LI
CVNA
DDOG
CRWD
OKTA
PLTR
SNOW
SMCI
MU
AMAT
LRCX
ASML
ORCL
SAP
CSCO
FTNT
CHKP
VRTX
REGN
GILD
BIIB
AZN
PFE
MRNA
BMY
AMGN
LLY
ABBV
NVO
SNPS
CDNS
MCHP
NXPI
ON
ADI
TXN
CRSP
EXAS
ALGN
TDOC
ROKU
COIN
PYPL
HOOD
REGN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Recover Losses - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN
prnewswire.com
REGN
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
REGN
Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. (REGN) Investors – Lead Plaintiff Deadline on September 14, 2026
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN